In particular, in vivo blockade of IL-10 led to nearly complete abrogation of the protective effect of MS, which further emphasized the crucial role of IL-10 mediated by GSK-3β in suppressing the TLR-triggered signalling pathway. Here, IL10 is linked to myeloid sarcoma.